Related Experiment Videos
Composite sequential grafts for femorocrural bypass reconstruction: experience with a modified technique
Asif Mahmood1, Andrew Garnham, Martin Sintler
1Department of Vascular Surgery, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK. amahmood27@hotmail.com
Journal of Vascular Surgery
|October 9, 2002
Summary
Composite sequential bypass grafting offers a viable solution for critical limb ischemia when autologous vein is insufficient. This method provides satisfactory limb salvage and patency rates, even with an occluded popliteal artery segment.
Area of Science:
- Vascular Surgery
- Reconstructive Surgery
Background:
- Evaluates a modified composite sequential femorocrural bypass graft technique.
- Grafts combine prosthetic femoropopliteal and autologous vein crural sections.
- Utilizes an intermediate anastomosis on the above-knee popliteal artery.
Purpose of the Study:
- To assess the efficacy of a modified composite sequential femorocrural bypass graft.
- To determine its suitability for patients with critical lower limb ischemia and insufficient autologous vein.
- To investigate the impact of popliteal artery conditions on graft outcomes.
Main Methods:
- Retrospective case-note study of 68 grafts in 65 patients (1985-2000).
- Patients had critical limb ischemia and inadequate long saphenous vein.
- Grafts used arm veins or short saphenous veins when long saphenous vein was unavailable.
- Popliteal artery disobliteration performed in 32% of cases with occluded segments.
Main Results:
- Achieved 2-year cumulative primary patency of 68%, secondary patency of 73%, and limb salvage of 75%.
- Localized popliteal artery disobliteration did not significantly compromise graft patency (P =.07).
Conclusions:
- Composite sequential grafting is a satisfactory option for limb revascularization when autologous vein is insufficient.
- An occluded above-knee popliteal artery segment is not a contraindication for this procedure.
- This technique offers a viable reconstructive solution for critical lower limb ischemia.